BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30701218)

  • 1. Hodgkin's lymphoma in a patient on adalimumab treatment for psoriasis.
    Alballa N; Alyousef A; Alamari A; Alhumidi AA; Zayed MA; Zeitouni L; Alsaif FM
    AME Case Rep; 2018; 2():49. PubMed ID: 30701218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Central Nervous System Lymphoma in a Patient on Adalimumab Therapy for Chronic Plaque Psoriasis.
    Farah RA; Alduaij A; Ugas C; Navarro R
    World Neurosurg; 2020 Jul; 139():260-263. PubMed ID: 32247793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of post-adalimumab vitiligo with secukinumab in a patient with psoriasis vulgaris.
    Palazzo G
    Oxf Med Case Reports; 2020 Jan; 2020(1):omz134. PubMed ID: 32038878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's Lymphoma in the Context of Psoriasis Vulgaris Treated With Immunosuppressive Therapy: A Case Report and Review of Literature.
    Alali Z; Al Ashour BH; Alrefaee M
    Cureus; 2021 Nov; 13(11):e19490. PubMed ID: 34912631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis.
    Ahdout J; Haley JC; Chiu MW
    J Am Acad Dermatol; 2010 May; 62(5):874-9. PubMed ID: 19913942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
    Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
    J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab in Chronic Plaque Psoriasis: A Clinical Guide.
    Wu JJ; Valdecantos WC
    J Drugs Dermatol; 2017 Aug; 16(8):779-790. PubMed ID: 28809993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab-induced scalp psoriasis with severe alopecia.
    Özkur E; Altunay İK; Leblebici C; Topkarcı Z; Erdem Y
    Dermatol Ther; 2019 Sep; 32(5):e13033. PubMed ID: 31350777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium marinum infection contracted from seaweed wrap in a psoriasis patient undergoing treatment with adalimumab.
    Timoney I; Lynch M; Timoney L; Feeney E; Kirby B
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor α antagonist-associated psoriasis in inflammatory diseases: an analysis of the FDA adverse event reporting system.
    Kip KE; Swoger JM; Grandinetti LM; Barrie AM; Greer JB; Regueiro MD
    Inflamm Bowel Dis; 2013 May; 19(6):1164-72. PubMed ID: 23518804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab: in plaque psoriasis.
    Croom KF; McCormack PL
    Am J Clin Dermatol; 2009; 10(1):43-50. PubMed ID: 19170412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab for treating childhood plaque psoriasis: a clinical trial evaluation.
    Di Lernia V
    Expert Opin Biol Ther; 2017 Dec; 17(12):1553-1556. PubMed ID: 28829204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naïve and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases.
    Takahashi N; Noda S; Taniguchi T; Adachi M
    Int J Dermatol; 2015 Oct; 54(10):1194-8. PubMed ID: 26016819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.
    Saraceno R; Bavetta M; Zangrilli A; Chiricozzi A; Potenza C; Chimenti S; Chimenti MS
    Expert Opin Biol Ther; 2013 Sep; 13(9):1325-34. PubMed ID: 23930916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of adalimumab in generalized pustular psoriasis.
    Zangrilli A; Papoutsaki M; Talamonti M; Chimenti S
    J Dermatolog Treat; 2008; 19(3):185-7. PubMed ID: 18569276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab: A Review in Chronic Plaque Psoriasis.
    Burness CB; McKeage K
    Drugs; 2015 Dec; 75(18):2119-30. PubMed ID: 26586242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab administration after infliximab therapy is a successful treatment strategy for generalized pustular psoriasis.
    Matsumoto A; Komine M; Karakawa M; Kishimoto M; Ohtsuki M
    J Dermatol; 2017 Feb; 44(2):202-204. PubMed ID: 27743397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab.
    Korta DZ; Ochieng P; Fishman D; Katz SE
    Dermatol Online J; 2015 Jan; 21(1):. PubMed ID: 25612132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis treatment in patients with sickle cell disease.
    Pulusani S; McMurray SL; Jensen K; Jones AV
    Cutis; 2019 Feb; 103(2):93-94. PubMed ID: 30893386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.